PRAMS: Peer-support To Reduce Antenatal Maternal Smoking
Launched by KING'S COLLEGE LONDON · Sep 12, 2024
Trial Information
Current as of August 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The PRAMS trial is designed to explore whether an online peer support group can help pregnant women who smoke quit smoking and stay smoke-free. The study will compare two groups: one group will receive the usual care along with access to the peer support group, while the other group will only receive the usual care. This trial is important because smoking during pregnancy can harm both the mother and the baby, and finding effective support strategies is crucial.
To participate in this trial, women need to be pregnant and smoking at the start of their pregnancy. They must also have a mobile phone to access the online support group. However, women under 16 years old are not eligible to join. While the trial is not yet recruiting participants, those who take part can expect to receive support from other women in similar situations, which may help them in their journey to quit smoking.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant
- • Smoking at beginning of pregnancy
- • Access to mobile phone
- Exclusion Criteria:
- • Under 16 years of age
About King's College London
King's College London is a prominent research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the college leverages its extensive expertise in medicine, neuroscience, and public health to conduct rigorous studies aimed at improving patient outcomes. As a sponsor of clinical trials, King's College London prioritizes ethical standards, participant safety, and scientific integrity, fostering an environment that encourages groundbreaking research and the translation of findings into clinical practice. Through its state-of-the-art facilities and a diverse network of researchers, the institution strives to address critical health challenges and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported